Log in to save to my catalogue

Tirzepatide: First Approval

Tirzepatide: First Approval

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2689055596

Tirzepatide: First Approval

About this item

Full title

Tirzepatide: First Approval

Author / Creator

Publisher

Cham: Springer International Publishing

Journal title

Drugs (New York, N.Y.), 2022-07, Vol.82 (11), p.1213-1220

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Tirzepatide (Mounjaro™) is a single molecule that combines dual agonism of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Native GIP and GLP-1 are incretin hormones that stimulate insulin secretion and decrease glucagon secretion. GIP also plays a role in nutrient and energy metabolism, while GLP-1...

Alternative Titles

Full title

Tirzepatide: First Approval

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2689055596

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2689055596

Other Identifiers

ISSN

0012-6667

E-ISSN

1179-1950

DOI

10.1007/s40265-022-01746-8

How to access this item